Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Chaffanet, M"" wg kryterium: Wszystkie pola

  Lista filtrów
Wyrównaj
Wyświetlanie 1-50 z 1421
Tytuł:
A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study
Autorzy:
Collignon, A.
Hospital, M. A.
Montersino, C.
Courtier, F.
Charbonnier, A.
Saillard, C.
D’Incan, E.
Mohty, B.
Guille, A.
Adelaïde, J.
Carbuccia, N.
Garnier, S.
Mozziconacci, M. J.
Zemmour, C.
Pakradouni, J.
Restouin, A.
Castellano, R.
Chaffanet, M.
Birnbaum, D.
Collette, Y.
Vey, N.
Pokaż więcej
Źródło:
Blood Cancer Journal. 10(6)
Czasopismo naukowe
Szczegóły
Tytuł:
ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines.
Autorzy:
Udu-Ituma S; Equipe Labellisée Ligue Nationale Contre le Cancer, Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France.; Department of Biology, Alex Ekwueme Federal University Ndufu-Alike Ikwo, Abakaliki P.M.B. 1010, Ebonyi State, Nigeria.; European Center for Research in Medical Imaging, Aix-Marseille University, 13005 Marseille, France.
Adélaïde J; Equipe Labellisée Ligue Nationale Contre le Cancer, Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France.
Le TK; Equipe Labellisée Ligue Nationale Contre le Cancer, Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France.; European Center for Research in Medical Imaging, Aix-Marseille University, 13005 Marseille, France.
Omabe K; Equipe Labellisée Ligue Nationale Contre le Cancer, Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France.
Finetti P; Equipe Labellisée Ligue Nationale Contre le Cancer, Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France.
Paris C; Equipe Labellisée Ligue Nationale Contre le Cancer, Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France.
Guille A; Equipe Labellisée Ligue Nationale Contre le Cancer, Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France.
Bertucci F; Equipe Labellisée Ligue Nationale Contre le Cancer, Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France.
Birnbaum D; Equipe Labellisée Ligue Nationale Contre le Cancer, Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France.
Rocchi P; Equipe Labellisée Ligue Nationale Contre le Cancer, Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France.; European Center for Research in Medical Imaging, Aix-Marseille University, 13005 Marseille, France.
Chaffanet M; Equipe Labellisée Ligue Nationale Contre le Cancer, Predictive Oncology Laboratory, Marseille Research Cancer Center, INSERM U1068, CNRS U7258, Institut Paoli-Calmettes, Aix Marseille University, 13009 Marseille, France.
Pokaż więcej
Źródło:
Pharmaceutics [Pharmaceutics] 2023 Jul 11; Vol. 15 (7). Date of Electronic Publication: 2023 Jul 11.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Loss of AF6/afadin, a marker of poor outcome in breast cancer, induces cell migration, invasiveness and tumor growth
Autorzy:
Fournier, GAff1, Aff4, Aff5
Cabaud, OAff1, Aff4, Aff5
Josselin, EAff1, Aff4, Aff5
Chaix, AAff2, Aff4, Aff5
Adélaïde, JAff4, Aff5
Isnardon, DAff4, Aff5
Restouin, AAff3, Aff4, Aff5
Castellano, RAff3, Aff4, Aff5
Dubreuil, PAff2, Aff4, Aff5
Chaffanet, MAff1, Aff4, Aff5
Birnbaum, D
Lopez, MAff1, Aff4, Aff5, IDonc2011106_cor12
Pokaż więcej
Źródło:
Oncogene. 30(36):3862-3874
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial.
Autorzy:
Billon E; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Gravis G; Department of Medical Oncology, Institut Paoli-Calmettes, 13009 Marseille, France.
Guille A; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Carbuccia N; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Adelaide J; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Garnier S; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Finetti P; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Denicolaï E; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Sfumato P; Biostatistics Unit, Institut Paoli-Calmettes, 13009 Marseille, France.
Brunelle S; Department of Imaging, Institut Paoli-Calmettes, 13009 Marseille, France.
Thomassin-Piana J; Department of Biopathology, Institut Paoli-Calmettes, 13009 Marseille, France.
Pignot G; Department of Urology, Institut Paoli-Calmettes, 13009 Marseille, France.
Walz J; Department of Urology, Institut Paoli-Calmettes, 13009 Marseille, France.
Chabannon C; Biobank, Department of Hematology, Institut Paoli-Calmettes, 13009 Marseille, France.
Pakradouni J; Department of Clinical Research and Innovation, Institut Paoli-Calmettes, 13009 Marseille, France.
Sabatier R; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Vicier C; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Popovici C; Department of Oncogenetics, Institut Paoli-Calmettes, 13009 Marseille, France.
Mamessier E; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Gonçalves A; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.; Department of Medical Oncology, Institut Paoli-Calmettes, 13009 Marseille, France.
Birnbaum D; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Chaffanet M; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.
Bertucci F; Laboratory of Predictive Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 13009 Marseille, France.; Department of Medical Oncology, Institut Paoli-Calmettes, 13009 Marseille, France.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 May 03; Vol. 14 (9). Date of Electronic Publication: 2022 May 03.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Gene expression profiling separates chronic myelomonocytic leukemia in two molecular subtypes
Autorzy:
Gelsi-Boyer, VAff1, Aff7, Aff5, Aff2, Aff3
Cervera, NAff1, Aff7, Aff5
Bertucci, FAff1, Aff7, Aff5, Aff3
Trouplin, VAff1, Aff7, Aff5, Aff2
Remy, VAff1, Aff7, Aff5
Olschwang, SAff1, Aff7, Aff5
Chaffanet, MAff1, Aff7, Aff5
Vey, N
Mozziconacci, M-JAff1, Aff7, Aff5, Aff2
Birnbaum, DAff1, Aff7, Aff5, ID2404805_cor10
Pokaż więcej
Źródło:
Leukemia. 21(11):2359-2362
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer
Autorzy:
Letessier, A
Garrido-Urbani, S
Ginestier, C
Fournier, G
Esterni, BAff3, Aff4
Monville, F
Adélaïde, J
Geneix, J
Xerri, LAff5, Aff6
Dubreuil, P
Viens, PAff4, Aff6
Charafe-Jauffret, EAff1, Aff5, Aff6
Jacquemier, JAff1, Aff5
Birnbaum, DAff1, ID1209772_cor14
Lopez, M
Chaffanet, M
Pokaż więcej
Źródło:
Oncogene. 26(2):298-307
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation
Autorzy:
Murati, AAff1, Aff2
Gelsi-Boyer, VAff1, Aff2, Aff3
Adélaïde, J
Perot, C
Talmant, P
Giraudier, S
Lodé, L
Letessier, A
Delaval, B
Brunel, V
Imbert, M
Garand, R
Xerri, LAff2, Aff3
Birnbaum, D
Mozziconacci, M JAff1, Aff2, ID2403879_cor15
Chaffanet, M
Pokaż więcej
Źródło:
Leukemia. 19(9):1692-1696
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial.
Autorzy:
Bertucci F; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France. .; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. .
Gonçalves A; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Guille A; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Adelaïde J; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Garnier S; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Carbuccia N; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Billon E; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Finetti P; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Sfumato P; Biostatistics Unit, Institut Paoli-Calmettes, Marseille, France.
Monneur A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Pécheux C; Department of Medical genetics, Hôpital Timone Enfants, AP-HM, Marseille, France.
Khran M; Department of Medical genetics, Hôpital Timone Enfants, AP-HM, Marseille, France.; Aix-Marseille University, Inserm, U1251-MMG, Marseille Medical Genetics, Marseille, France.
Brunelle S; Department of Imaging, Institut Paoli-Calmettes, Marseille, France.
Mescam L; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France.
Thomassin-Piana J; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France.
Poizat F; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France.
Charafe-Jauffret E; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France.
Turrini O; Department of Surgical Oncology, Institut Paoli-Calmettes, Marseille, France.
Lambaudie E; Department of Surgical Oncology, Institut Paoli-Calmettes, Marseille, France.
Provansal M; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Extra JM; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Madroszyk A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Gilabert M; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Sabatier R; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Vicier C; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Mamessier E; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Chabannon C; Biobank, Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
Pakradouni J; Department of Clinical Research and Innovation, Institut Paoli-Calmettes, Marseille, France.
Viens P; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
André F; Department of Medical Oncology, Gustave Roussy Cancer Campus, UMR981 Inserm, Villejuif, France.; Paris Sud University, Orsay, France.
Gravis G; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Popovici C; Department of Oncogenetics, Institut Paoli-Calmettes, Marseille, France.
Birnbaum D; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Chaffanet M; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.
Pokaż więcej
Źródło:
Genome medicine [Genome Med] 2021 May 18; Vol. 13 (1), pp. 87. Date of Electronic Publication: 2021 May 18.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor*
Genomics*/methods
High-Throughput Nucleotide Sequencing*
Neoplasms/*diagnosis
Neoplasms/*genetics
Adult ; Aged ; Aged, 80 and over ; Biopsy ; Combined Modality Therapy ; Comparative Genomic Hybridization ; Disease Management ; Disease Susceptibility ; Female ; Genetic Variation ; Humans ; Male ; Middle Aged ; Molecular Diagnostic Techniques/methods ; Molecular Diagnostic Techniques/standards ; Neoplasm Grading ; Neoplasm Staging ; Neoplasms/mortality ; Neoplasms/therapy ; Precision Medicine/methods ; Prognosis ; Prospective Studies ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Mutations and deletions of ARID1A in breast tumors
Autorzy:
Cornen, SAff1, Aff4, Aff5, Aff6
Adelaide, JAff1, Aff4, Aff5, Aff6
Bertucci, FAff1, Aff4, Aff5, Aff6, Aff2, Aff3
Finetti, PAff1, Aff4, Aff5, Aff6
Guille, AAff1, Aff4, Aff5, Aff6
Birnbaum, D JAff1, Aff4, Aff5, Aff6
Birnbaum, DAff1, Aff4, Aff5, Aff6
Chaffanet, MAff1, Aff4, Aff5, Aff6, IDonc2011598_cor8
Pokaż więcej
Źródło:
Oncogene. 31(38):4255-4256
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Amplification and Expression of Viral Sequences and Oncogenes in Human Brain Tumors
Autorzy:
Benabid, A. L.
Chauvin, C.
Foote, A. M.
Suh, M.
Danik, M.
Laine, M.
Chaffanet, M.
Mercier, C.
Rost, N.
Pokaż więcej
Źródło:
Brain Oncology Biology, diagnosis and therapy : An international meeting on brain oncology, Rennes, France, September 4–5, 1986, held under the auspices of the Ministry of National Education, the University of Rennes and the Regional Hospital Rennes. 52:15-19
Książka elektroniczna
Szczegóły
Tytuł:
A Comparison of DNA Mutation and Copy Number Profiles of Primary Breast Cancers and Paired Brain Metastases for Identifying Clinically Relevant Genetic Alterations in Brain Metastases.
Autorzy:
Tyran M; Laboratoire d'Oncologie Prédictive, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Aix-Marseille Université, Institut Paoli-Calmettes, F-13009 Marseille, France. .; Département de Radiothérapie, Institut Paoli-Calmettes, 13009 Marseille, France. .
Carbuccia N; Laboratoire d'Oncologie Prédictive, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Aix-Marseille Université, Institut Paoli-Calmettes, F-13009 Marseille, France. .
Garnier S; Laboratoire d'Oncologie Prédictive, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Aix-Marseille Université, Institut Paoli-Calmettes, F-13009 Marseille, France. .
Guille A; Laboratoire d'Oncologie Prédictive, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Aix-Marseille Université, Institut Paoli-Calmettes, F-13009 Marseille, France. .
Adelaïde J; Laboratoire d'Oncologie Prédictive, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Aix-Marseille Université, Institut Paoli-Calmettes, F-13009 Marseille, France. .
Finetti P; Laboratoire d'Oncologie Prédictive, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Aix-Marseille Université, Institut Paoli-Calmettes, F-13009 Marseille, France. .
Toulzian J; Département d'Anatomopathologie, Institut Paoli-Calmettes, 13009 Marseille, France. .
Viens P; Département d'Oncologie Médicale, Institut Paoli-Calmettes, 13009 Marseille, France. .; Faculté de Médecine, Aix-Marseille Université, 13005 Marseille, France. .
Tallet A; Département de Radiothérapie, Institut Paoli-Calmettes, 13009 Marseille, France. .
Goncalves A; Laboratoire d'Oncologie Prédictive, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Aix-Marseille Université, Institut Paoli-Calmettes, F-13009 Marseille, France. .; Département d'Oncologie Médicale, Institut Paoli-Calmettes, 13009 Marseille, France. .; Faculté de Médecine, Aix-Marseille Université, 13005 Marseille, France. .
Metellus P; Département de Neurochirurgie et de Neuro-oncologie, Hôpital Privé Clairval, Ramsay-Générale de Santé and Institut de Neurophysiopathologie Equipe 10, UMR0751, CNRS, 13009 Marseille, France. .
Birnbaum D; Laboratoire d'Oncologie Prédictive, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Aix-Marseille Université, Institut Paoli-Calmettes, F-13009 Marseille, France. .
Chaffanet M; Laboratoire d'Oncologie Prédictive, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Aix-Marseille Université, Institut Paoli-Calmettes, F-13009 Marseille, France. .
Bertucci F; Laboratoire d'Oncologie Prédictive, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Aix-Marseille Université, Institut Paoli-Calmettes, F-13009 Marseille, France. .; Département d'Oncologie Médicale, Institut Paoli-Calmettes, 13009 Marseille, France. .; Faculté de Médecine, Aix-Marseille Université, 13005 Marseille, France. .
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2019 May 13; Vol. 11 (5). Date of Electronic Publication: 2019 May 13.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Inflammatory breast cancer in 210 patients: A retrospective study on epidemiological, anatomo-clinical features and therapeutic results.
Autorzy:
Manai M; Department of Immuno-Histo-Cytology, Salah Azaiez Institute, Tunis 1006, Tunisia.; Medical Oncology Service, University Hospital Abderrahmane Mami, Ariana 2080, Tunisia.; Laboratory of Biochemistry and Molecular Biology, Department of Biology, Faculty of Sciences, University of Tunis El Manar, Ariana 2092, Tunisia.; Predictive Oncology Τeam, Marseille Cancer Research Center (INSERM UMR1068; IFR137), Paoli-Calmettes Institute, 13009 Marseille, France.
Finetti P; Predictive Oncology Τeam, Marseille Cancer Research Center (INSERM UMR1068; IFR137), Paoli-Calmettes Institute, 13009 Marseille, France.
Mejri N; Medical Oncology Service, University Hospital Abderrahmane Mami, Ariana 2080, Tunisia.
Athimni S; Medical Oncology Service, University Hospital Abderrahmane Mami, Ariana 2080, Tunisia.
Birnbaum D; Predictive Oncology Τeam, Marseille Cancer Research Center (INSERM UMR1068; IFR137), Paoli-Calmettes Institute, 13009 Marseille, France.
Bertucci F; Predictive Oncology Τeam, Marseille Cancer Research Center (INSERM UMR1068; IFR137), Paoli-Calmettes Institute, 13009 Marseille, France.; UFR of Medicine, Aix Marseille University, 13009 Marseille, France.; Department of Medical Oncology, Marseille Cancer Research Center (INSERM UMR1068; IFR137), Paoli-Calmettes Institute, Aix Marseille University, 13009 Marseille, France.
Rahal K; Department of Immuno-Histo-Cytology, Salah Azaiez Institute, Tunis 1006, Tunisia.
Gamoudi A; Department of Immuno-Histo-Cytology, Salah Azaiez Institute, Tunis 1006, Tunisia.
Chaffanet M; Predictive Oncology Τeam, Marseille Cancer Research Center (INSERM UMR1068; IFR137), Paoli-Calmettes Institute, 13009 Marseille, France.
Manai M; Laboratory of Biochemistry and Molecular Biology, Department of Biology, Faculty of Sciences, University of Tunis El Manar, Ariana 2092, Tunisia.
Boussen H; Medical Oncology Service, University Hospital Abderrahmane Mami, Ariana 2080, Tunisia.; Laboratory of Biochemistry and Molecular Biology, Department of Biology, Faculty of Sciences, University of Tunis El Manar, Ariana 2092, Tunisia.; Oncology Radiotherapy Association for the Mediterranean, 75014 Paris, France.
Pokaż więcej
Źródło:
Molecular and clinical oncology [Mol Clin Oncol] 2019 Feb; Vol. 10 (2), pp. 223-230. Date of Electronic Publication: 2018 Nov 26.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value.
Autorzy:
Doghri R; Département d'Anatomie Pathologique, Institut Salah Azaiez, Bab Saadoun, Tunis 1006, Tunisia. .
Manai M; Département d'Anatomie Pathologique, Institut Salah Azaiez, Bab Saadoun, Tunis 1006, Tunisia. maroua.m@hotmail.com.; Département d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR7258, Aix-Marseille Université, 13007 Marseille, France. maroua.m@hotmail.com.; Département de Biologie, Unité de Biochimie et Biologie Moléculaire, Faculté des Sciences de Tunis, Université de Tunis El Manar, Tunis 1068, Tunisia. maroua.m@hotmail.com.
Finetti P; Département d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR7258, Aix-Marseille Université, 13007 Marseille, France. .
Driss M; Département d'Anatomie Pathologique, Institut Salah Azaiez, Bab Saadoun, Tunis 1006, Tunisia. .; Département de Biologie, Unité de Biochimie et Biologie Moléculaire, Faculté des Sciences de Tunis, Université de Tunis El Manar, Tunis 1068, Tunisia. .
Agavnian E; Département de Bio-Pathologie, Institut Paoli-Calmettes, 13009 Marseille, France. .
Lopez M; Département d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR7258, Aix-Marseille Université, 13007 Marseille, France. .
Elghardallou M; Département de Médicine Communautaire, Faculté de Médecine de Sousse, Sousse 4000, Tunisia. .
Charafe-Jauffret E; Département de Bio-Pathologie, Institut Paoli-Calmettes, 13009 Marseille, France.; UFR de Médecine, Aix Marseille Université, 13007 Marseille, France.
Manai M; Département de Biologie, Unité de Biochimie et Biologie Moléculaire, Faculté des Sciences de Tunis, Université de Tunis El Manar, Tunis 1068, Tunisia.
Chaffanet M; Département d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR7258, Aix-Marseille Université, 13007 Marseille, France. .
Birnbaum D; Département d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR7258, Aix-Marseille Université, 13007 Marseille, France. .
Mrad K; Département d'Anatomie Pathologique, Institut Salah Azaiez, Bab Saadoun, Tunis 1006, Tunisia. .
Bertucci F; Département d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR7258, Aix-Marseille Université, 13007 Marseille, France. .; UFR de Médecine, Aix Marseille Université, 13007 Marseille, France. .; Département d'Oncologie Médicale, Institut Paoli-Calmettes, 13009 Marseille, France. .
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2017 Dec 23; Vol. 19 (1). Date of Electronic Publication: 2017 Dec 23.
Typ publikacji:
Journal Article
MeSH Terms:
Myristoylated Alanine-Rich C Kinase Substrate/*metabolism
Ovarian Neoplasms/*metabolism
Ovarian Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Ovarian Epithelial ; Cell Line, Tumor ; Female ; Humans ; Middle Aged ; Multivariate Analysis ; Neoplasms, Glandular and Epithelial/metabolism ; Neoplasms, Glandular and Epithelial/pathology ; Prognosis ; Stromal Cells/metabolism ; Survival Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Castration-Resistant Prostate Cancer: From Uncovered Resistance Mechanisms to Current Treatments.
Autorzy:
Le, Thi Khanh (AUTHOR)
Duong, Quang Hieu (AUTHOR)
Baylot, Virginie (AUTHOR)
Fargette, Christelle (AUTHOR)
Baboudjian, Michael (AUTHOR)
Colleaux, Laurence (AUTHOR)
Taïeb, David (AUTHOR)
Rocchi, Palma (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Oct2023, Vol. 15 Issue 20, p5047. 17p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing.
Autorzy:
Garrote, Marta (AUTHOR)
López-Guerra, Mónica (AUTHOR)
Arellano-Rodrigo, Eduardo (AUTHOR)
Rozman, María (AUTHOR)
Carbonell, Sara (AUTHOR)
Guijarro, Francesca (AUTHOR)
Santaliestra, Marta (AUTHOR)
Triguero, Ana (AUTHOR)
Colomer, Dolors (AUTHOR)
Cervantes, Francisco (AUTHOR)
Álvarez-Larrán, Alberto (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Aug2023, Vol. 15 Issue 15, p3904. 13p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer.
Autorzy:
El Hejjioui, Brahim (AUTHOR)
Lamrabet, Salma (AUTHOR)
Amrani Joutei, Sarah (AUTHOR)
Senhaji, Nadia (AUTHOR)
Bouhafa, Touria (AUTHOR)
Malhouf, Moulay Abdelilah (AUTHOR)
Bennis, Sanae (AUTHOR)
Bouguenouch, Laila (AUTHOR)
Pokaż więcej
Źródło:
Diagnostics (2075-4418). Jun2023, Vol. 13 Issue 11, p1949. 29p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-50 z 1421

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies